AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations
AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations
Pre-seed investment supports the sustained growth and functionality of AddParts’ virtual storeroom technology.
Sheffield, UK – 29 April 2026 – AddParts, a UK-based technology company enabling pharmaceutical manufacturers to improve production continuity and reduce operational risk, has secured a six-figure pre-seed investment from SFC Capital to support its growth.
The move comes as pharmaceutical manufacturers face increasing pressure to mitigate operational risk, reduce dependency on fragile supply chains, and maintain continuous production in highly regulated environments. Across global manufacturing, unplanned downtime is estimated to cost hundreds of billions of pounds annually, with even short disruptions having significant financial and operational impact in high-value pharmaceutical production environments.
AddParts addresses this challenge through a virtual-first model that enables manufacturers to store, access, and reproduce critical components on demand, reducing reliance on traditional supply chains and long lead times.
At the core of AddParts’ offering is a virtual storeroom that enables manufacturers to take control of their critical parts data, ensuring components can be reproduced on demand, reducing reliance on OEMs, and enabling more resilient, proactive maintenance strategies.
“Unplanned downtime is a global challenge for pharmaceutical manufacturers, with real consequences for cost, output, and supply continuity,” said Tom Fripp, founder of AddParts. “By digitising critical components and making them available on demand, we’re helping manufacturers respond faster and operate more resiliently.”
As manufacturers seek to build more resilient, responsive operations, digital spare parts strategies are emerging as a critical component of modern pharmaceutical manufacturing.
Fripp continues: “Early customer engagements have demonstrated measurable operational benefits, including significantly reduced lead times and improved production continuity. In some cases, avoiding a single extended stoppage fully offsets the cost of implementing AddParts’ more proactive spare parts strategy.”
Beyond part replacement, AddParts supports manufacturers with reverse engineering of legacy components, digital capture of critical equipment, and engineering-led improvements that reduce failure risk and extend asset life. The firm operates under an ISO 9001-certified quality management system aligned with pharmaceutical manufacturing requirements, ensuring traceability, documentation, and compliance.
Supporting AddParts on its growth journey, SFC Capital’s Fund Principal, Ed Stevenson said: “AddParts gives manufacturers a digital record of their critical components, so they can reproduce what they need on demand instead of chasing OEMs. Tom has built something genuinely useful, and we're pleased to back him.”
AddParts was also supported by Venture.Community, an organisation that helps businesses in the South Yorkshire region of the UK raise investment. The programme played a key role in supporting the company’s development and preparing it for successful investment.
Executive Chairman and Founder, Peter Hopton said: “AddParts is a really exciting company. We liked the team, the depth of the product, and the traction with customers. The firm is solving a key pain point in regulated production lines worth millions of pounds in savings.”
This year, AddParts has also been recognised for its contribution to advanced manufacturing innovation in the pharma sector by the Made in Sheffield Awards and has been shortlisted in the Manufacturing Start-Up category.
Ends
About AddParts
AddParts is a UK-based digital manufacturing company specialising in spare parts solutions for regulated industries, including pharmaceutical manufacturing. By combining 3D scanning, digital asset management and advanced manufacturing, AddParts helps organisations reduce downtime, improve resilience and maintain production continuity.
About SFC Capital
SFC Capital is the UK’s most active seed-stage investor, providing seed capital and support to promising British startups. By combining` our leading investment funds with our angel syndicate, we have created a unique model that provides investors with diversified exposure to high-potential SEIS and EIS-qualifying businesses. Since 2012, SFC has invested in over 450 startups and partnered with the likes of British Business Investments to support innovation across all UK regions. To learn more about what we do and see our portfolio, visit sfccapital.com.
About Venture.Community
Venture.Community is where entrepreneurs come together to help each other – “Venture is a Team Sport”. A Mutually owned and democratically operated non-profit (Co-op), with 329 members in 7 countries and headquartered in Sheffield, South Yorkshire. Venture.Community operates a super-accelerator, co-working, trade missions and supports venture fundraising with both angel group and supporting venture capital funds. https://venture.community/
Media Contact:
Amie Scott
ramarketing
amie.scott@ramarketingpr.com
Editor Details
-
Company:
- ramarketing
-
Name:
- Amie Scott
- Email:
-
Telephone:
- +441912221242
- Website: